XINHUA PHARMA -H- (XIN.SG)
XINHUA PHARMA -H- (XIN.SG) operates in Diversified Metals & Mining.
XINHUA PHARMA -H- (XIN.SG) (XIN) - Total Liabilities
Latest total liabilities as of September 2024: €3.73 Billion EUR
Based on the latest financial reports, XINHUA PHARMA -H- (XIN.SG) (XIN) has total liabilities worth €3.73 Billion EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
XINHUA PHARMA -H- (XIN.SG) - Total Liabilities Trend (2016–2023)
This chart illustrates how XINHUA PHARMA -H- (XIN.SG)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
XINHUA PHARMA -H- (XIN.SG) Competitors by Total Liabilities
The table below lists competitors of XINHUA PHARMA -H- (XIN.SG) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dais Analytic Corp
PINK:DLYT
|
USA | $15.22 Million |
|
Telecom Italia SpA
STU:TQIR
|
Germany | €43.16 Billion |
Liability Composition Analysis (2016–2023)
This chart breaks down XINHUA PHARMA -H- (XIN.SG)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.77 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how XINHUA PHARMA -H- (XIN.SG)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for XINHUA PHARMA -H- (XIN.SG) (2016–2023)
The table below shows the annual total liabilities of XINHUA PHARMA -H- (XIN.SG) from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €3.51 Billion | -10.34% |
| 2022-12-31 | €3.92 Billion | +6.37% |
| 2021-12-31 | €3.68 Billion | -0.56% |
| 2020-12-31 | €3.70 Billion | +11.31% |
| 2019-12-31 | €3.33 Billion | +6.60% |
| 2018-12-31 | €3.12 Billion | +15.79% |
| 2017-12-31 | €2.69 Billion | +1.92% |
| 2016-12-31 | €2.64 Billion | -- |